Additionally, strong nuclear STAT6 IHC staining, which can be used instead of costly molecular tests for detecting NAB2-STAT6 fusion genes, has been used to reliably differentiate SFT from other soft tissue tumors, tumors of the head and neck, gynecologic tract, and prostate[21]. Here, STAT6 is linked to head and neck neoplasm.